Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 177
Filter
1.
Bull Exp Biol Med ; 151(1): 16-21, 2011 May.
Article in English | MEDLINE | ID: mdl-22442793

ABSTRACT

Laser Doppler flowmetry showed that aspirin can induce blood flow reduction and transitory manifold increase or decrease in vascular tone in rat skin and kidneys. The dynamics is more illustrative when parameters of individual animals are evaluated and depends on the areas of blood flow recording. Deaths and reduction of narcotic sleep duration were noted in concomitant use of nembutal and aspirin.


Subject(s)
Aspirin/administration & dosage , Microcirculation/drug effects , Microvessels/drug effects , Animals , Aspirin/antagonists & inhibitors , Kidney/blood supply , Kidney/drug effects , Laser-Doppler Flowmetry , Pentobarbital/administration & dosage , Pentobarbital/antagonists & inhibitors , Rats , Skin/blood supply , Skin/drug effects , Sleep/drug effects
2.
J Pharmacol Exp Ther ; 331(1): 142-52, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19641166

ABSTRACT

The gamma-aminobutyric acid (GABA)(A) receptors mediating the discriminative stimulus effects of ethanol were studied by comparing the potency of ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazol(1,5-a)benzodiazepine-3-carboxylate (Ro15-4513) and ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol(1,5-a)-benzodiazepine-3-carboxylate (flumazenil, Ro15-1788) to antagonize ethanol, pentobarbital (PB), and midazolam substitution for ethanol. Ro15-4513 has high affinity for receptors containing alpha(4/6) and alpha(5) subunits and lower affinity for alpha(1), alpha(2), and alpha(3) subunits. Flumazenil is nonselective for GABA(A) receptors containing alpha(1), alpha(2), alpha(3), and alpha(5) subunits and has low affinity for alpha(4/6)-containing receptors. Male (n = 9) and female (n = 8) cynomolgus monkeys (Macaca fascicularis) were trained to discriminate ethanol (1.0 or 2.0 g/kg i.g., 30-min pretreatment) from water. Ethanol, PB, and midazolam dose-dependently substituted for ethanol (80% ethanol-appropriate responding). Ro15-4513 (0.003-0.56 mg/kg i.m., 5-min pretreatment) shifted the ethanol, PB, and midazolam dose-response functions rightward in a vast majority of monkeys tested (15/15, 16/17, and 11/12, respectively). In contrast, flumazenil (0.30-10.0 mg/kg i.m., 5-min pretreatment) shifted the ethanol, PB, and midazolam dose-response functions rightward in 9 of 16, 12 of 16, and 7 of 9 monkeys tested, respectively. In the monkeys showing antagonism with both Ro15-4513 and flumazenil, ethanol and PB substitution were antagonized more potently by Ro15-4513 than by flumazenil, whereas midazolam substitution was antagonized with similar potency. There were no sex or training dose differences, with the exception that flumazenil failed to antagonize ethanol substitution in males trained to discriminate 2.0 g/kg ethanol. GABA(A) receptors with high affinity for Ro15-4513 (i.e., containing alpha(4/6) and alpha(5) subunits) may be particularly important mediators of the multiple discriminative stimulus effects of ethanol through GABA(A) receptor systems.


Subject(s)
Discrimination Learning/physiology , Ethanol/antagonists & inhibitors , Midazolam/antagonists & inhibitors , Pentobarbital/antagonists & inhibitors , Protein Subunits/physiology , Receptors, GABA-A/physiology , Animals , Azides/pharmacology , Benzodiazepines/pharmacology , Discrimination Learning/drug effects , Dose-Response Relationship, Drug , Ethanol/pharmacology , Female , Flumazenil/pharmacology , Macaca fascicularis , Male , Midazolam/pharmacology , Pentobarbital/pharmacology , Protein Subunits/classification , Receptors, GABA-A/classification
3.
Pharmacol Biochem Behav ; 90(3): 399-403, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18466960

ABSTRACT

Semen Zizhiphi Spinozae has been used extensively for the treatment of insomnia. This study investigated the effect and possible mechanism of action of spinosin (also known as 2''-beta-o-glucopyranosyl swertisin), a major constituent of semen Zizhiphi Spinozae, on sleep in mice. The present results showed that spinosin significantly and dose-dependently augmented pentobarbital (45 mg/kg, i.p.)-induced sleep, reflected by increased sleep time and reduced sleep latency assessed with the loss-of-righting reflex, and these effects were potentiated by the 5-hydroxytryptamine (serotonin) precursor 5-hydroxytryptophan (5-HTP, 2.5 mg/kg,i.p.). With a subhypnotic dose of pentobarbital (28 mg/kg, i.p.), spinosin significantly increased the rate of sleep onset and exhibited a synergistic effect with 5-HTP (2.5 mg/kg, i.p.). Pretreatment with p-chlorophenylalanine (PCPA, 300 mg/kg, s.c.), an inhibitor of tryptophan hydroxylase, significantly decreased pentobarbital-induced sleep time, and spinosin significantly reversed this effect. The dopamine precursor L-3-(3, 4-dihydroxyphenylalanine (L-DOPA) reduced pentobarbital-induced sleep, an effect not significantly affected by spinosin. These results suggest that spinosin potentiated pentobarbital-induced sleep via a serotonergic mechanism.


Subject(s)
Flavonoids/pharmacology , Hypnotics and Sedatives/pharmacology , Pentobarbital/pharmacology , Serotonin/physiology , Sleep/drug effects , Ziziphus/chemistry , 5-Hydroxytryptophan/pharmacology , Animals , Dopamine Agents/pharmacology , Drug Synergism , Fenclonine/pharmacology , Hypnotics and Sedatives/antagonists & inhibitors , Levodopa/pharmacology , Male , Mice , Mice, Inbred ICR , Pentobarbital/antagonists & inhibitors , Postural Balance/drug effects , Reflex/drug effects , Serotonin Agents/pharmacology
4.
Brain Res Bull ; 73(1-3): 103-7, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17499643

ABSTRACT

A conformationally constrained peptidomimetic derived from the endocrine and neuroactive tripeptide thyrotropin-releasing hormone (pGlu-His-Pro-NH(2)) was synthesized by convenient solid-phase organic chemistry and evaluated as a potential central nervous system agent. While this ethylene-bridged peptide analogue has been reported to lack the hormonal effect of the native peptide, we have shown in animal models that it possesses central nervous system activity characteristic of thyrotropin-releasing hormone. Compared to control, the peptidomimetic showed significant analeptic and antidepressant-like potencies. Moreover, an enhanced selectivity in antidepressant-like effect was measured when compared to that of the native peptide. Immobilized artificial membrane chromatography and in vitro metabolic stability studies also revealed that this constrained peptidomimetic has higher affinity to the blood-brain barrier than the native peptide and is metabolically stable. Consequently, this structure may be used as a template to design centrally selective and metabolically stable thyrotropin-releasing hormone analogues as potential neuropharmaceutical agents.


Subject(s)
Thyrotropin-Releasing Hormone/analogs & derivatives , Thyrotropin-Releasing Hormone/pharmacology , Animals , Antidepressive Agents , Brain/metabolism , Central Nervous System Stimulants , Chromatography , Hypnotics and Sedatives/antagonists & inhibitors , Hypnotics and Sedatives/pharmacology , In Vitro Techniques , Mice , Molecular Conformation , Motor Activity/drug effects , Pentobarbital/antagonists & inhibitors , Pentobarbital/pharmacology , Peptides/chemical synthesis , Permeability , Sleep/drug effects , Swimming/psychology , Thyrotropin-Releasing Hormone/pharmacokinetics
5.
Phytother Res ; 20(10): 901-5, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16909444

ABSTRACT

On oral administration, Ginkgo biloba phytosomes significantly reduced pentobarbitone-induced sleeping time, produced an alteration in the general behaviour pattern, increased spontaneous motility and inhibited the chlorpromazine-induced blockade of conditioned and unconditioned responses in rodents. They exhibited both antiamnestic and antidepressant activities in the scopolamine-induced amnesia test and behavioural despair test, respectively. However, the phytosomes failed to show anticonvulsant activity. The observations suggest that the G. biloba phytosomes possess moderate antiamnestic/nootropic activity.


Subject(s)
Central Nervous System Agents/pharmacology , Ginkgo biloba/chemistry , Plant Extracts/pharmacology , Animals , Anticonvulsants/chemistry , Anticonvulsants/isolation & purification , Anticonvulsants/pharmacology , Antidepressive Agents/chemistry , Antidepressive Agents/isolation & purification , Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Central Nervous System Agents/chemistry , Central Nervous System Agents/isolation & purification , Drug Evaluation, Preclinical , Electroshock , Female , Isoniazid/antagonists & inhibitors , Male , Mice , Nootropic Agents/chemistry , Nootropic Agents/isolation & purification , Nootropic Agents/pharmacology , Pentobarbital/antagonists & inhibitors , Phosphatidylcholines/chemistry , Phosphatidylcholines/pharmacology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Rats , Rats, Wistar , Scopolamine/antagonists & inhibitors , Sleep
6.
Acta Physiol (Oxf) ; 187(4): 479-88, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16866778

ABSTRACT

AIM: The roles of alpha-subunits on the gamma-aminobutyric acid (GABA)-site antagonism and pentobarbital actions were examined in rat recombinant GABA(A) receptors in Xenopus oocytes. METHODS: Experiments were performed with binary and ternary GABA(A) receptors containing alpha1-, alpha4- or alpha5-subunit by the two-electrode voltage-clamp technique. RESULTS: The potency of GABA was significantly higher in the alpha1beta2, alpha4beta2 and alpha5beta2 receptors compared with the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors. However, the alpha5beta2 receptor possessed significantly lower GABA efficacy compared with the alpha5beta2gamma2L receptor. While the gamma2-subunit was essential to the potency of GABA, its influence on the apparent GABA-site antagonism was less profound. The antagonist affinity constants (K(B)) of bicuculline inhibition and slopes of Schild plots were similar between all types of ternary and binary receptors except alpha5beta2 receptor which was not tested. The pK(B)s and IC(50)s of the GABA-site antagonism were not significantly different between the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors. Bicuculline blocked pentobarbital-activated currents in a reversible and non-competitive manner with the alpha1beta2gamma2L, alpha4beta2gamma2L, and alpha5beta2gamma2L receptors, indicating an allosteric inhibition of the GABA-site. No significant difference of bicuculline potencies in inhibiting GABA- and pentobarbital-activated currents was found between the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors. CONCLUSION: The GABA-site antagonism does not depend on the subtype of alpha-subunits. Similarly, pentobarbital activates ternary receptors composed of different alpha-subunits in a bicuculline-sensitive manner. The potencies of bicuculline to inhibit pentobarbital-activated currents are identical with receptors containing alpha1, alpha4 or alpha5-subunit. The alpha1beta2 and alpha4beta2 receptors possess higher GABA potencies compared with the alpha1beta2gamma2L and alpha4beta2gamma2L receptors.


Subject(s)
GABA Antagonists/pharmacology , Pentobarbital/pharmacology , Receptors, GABA-A/drug effects , Animals , Bicuculline/analogs & derivatives , Bicuculline/pharmacology , Dose-Response Relationship, Drug , Female , Oocytes/metabolism , Patch-Clamp Techniques , Pentobarbital/antagonists & inhibitors , Rats , Receptors, GABA-A/metabolism , Recombinant Proteins/pharmacology , Xenopus
7.
Acta Pharmacol Sin ; 26(5): 527-32, 2005 May.
Article in English | MEDLINE | ID: mdl-15842768

ABSTRACT

AIM: To comparatively study the pharmacological profiles of 3-methyl-3-azabicyclo(3,3,1)nonanyl-9-alpha-yl-alpha-cyclopentyl-alpha-phenyl-alpha-glycolate (phencynonate hydrochloride, CPG), an anticholinergic agent, and its enantiomers [R(-)-and S(+)-CPG]. METHODS: The affinity and relative efficacy were tested using radioligand-binding assay with muscarinic acetylcholine receptors from rat cerebral cortex. The pharmacological activities were assessed in three individual experiments: (1) potentiating the effect of subthreshold hypnotic dose of sodium pentobarbital; (2) inhibiting oxotremorine-induced salivation; and (3) inhibiting the contractile response to carbachol. RESULTS: The order of potency of phencynonate hydrochloride and its optical isomers to inhibit the binding of [3H]quinuclidinyl benzilate ([3H]QNB) was R(-)-CPG (K(i)=46.49+/-1.27 nmol/L)>CPG(K(i)=271.37+/-72.30nmol/L)>S(+)-CPG(K(i)=1263.12+/-131.64 nmol/L). The results showed that R(-)-CPG had the highest affinity to central muscarinic receptors among the three compounds, but did not show any central depressant effects at dose from 10.00 to 29.15 mg/kg. CPG increased the effects of subthreshold hypnotic dose of sodium pentobarbital induced-sleeping [the ED50+/-95% LC value was 21.06+/-3.04 mg/kg]. CPG and R(-)-CPG displayed nearly equipotent effect in depressing oxotremorine-induced salivation [the ED50 +/-95% LC for R(-) and CPG were 1.10+/-0.28 and 1.07+/-0.15 mg/kg, respectively], and the contractile response to carbachol (pA(2) values for R (-) and CPG were 6.84 and 6.80, respectively). S(+)-CPG presented the lowest anticholinergic profiles, but could potentate effects of its enantiomers in some manner. CONCLUSIONS: These data suggested that R(-)-CPG acted as an eutomer in racemate and a competitive antagonist to acetylcholine muscarinic receptors, but S(+)-CPG was less active in comparison to R(-)-CPG and its racemate. The central depressant effects of R(-)-CPG and S(+)-CPG were lower in comparison to its racemate.


Subject(s)
Aza Compounds/pharmacology , Cerebral Cortex/metabolism , Cholinergic Antagonists/pharmacology , Glycolates/pharmacology , Muscle Contraction/drug effects , Receptors, Muscarinic/metabolism , Animals , Aza Compounds/chemistry , Binding, Competitive , Carbachol/antagonists & inhibitors , Cholinergic Antagonists/chemistry , Female , Glycolates/chemistry , Guinea Pigs , Hypnotics and Sedatives/antagonists & inhibitors , Male , Mice , Oxotremorine/antagonists & inhibitors , Pentobarbital/antagonists & inhibitors , Quinuclidinyl Benzilate/pharmacology , Radioligand Assay , Rats , Salivation/drug effects , Sleep/drug effects , Stereoisomerism
8.
J Neurophysiol ; 88(6): 3067-77, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12466430

ABSTRACT

Pentobarbital, a general anesthetic, has received extensive study for its ability to potentiate inhibition at GABA(A) subtype of receptors for GABA. Using whole cell current-clamp techniques and bath applications, we determined the effects of pentobarbital and GABA receptor antagonists on the membrane properties and tonic or burst firing of medial geniculate neurons in thalamic slices. Pentobarbital (0.01-200 microM) induced depressant effects in 50 of 66 neurons (76%). Pentobarbital hyperpolarized neurons by a mean of 3 mV and decreased the number of action potentials in tonic firing, evoked by current pulse injection from near the resting potential. Pentobarbital also decreased burst firing or low threshold Ca(2+)-spikes, evoked by current pulse injection into neurons at potentials hyperpolarized from rest. The blockade of tonic and burst firing, as well as low threshold Ca(2+)-spikes, was surmountable by increasing the amplitude of input current. The GABA(A) receptor antagonists, bicuculline (100 microM) and picrotoxinin (50-100 microM), did not block the depressant effects of pentobarbital (10 microM). The GABA(B) receptor antagonist, saclofen (200 microM), and GABA(C) receptor antagonist, (1,2,3,6-tetrahydropyridine-4-yl)methylphosphinate (10-50 microM), did not significantly alter the depressant effects. Pentobarbital produced excitatory effects (0.1-50 microM) on 11 neurons (17%) but had no effects on 5 neurons (7%). The excitation consisted of approximately 3 mV depolarization, increased tonic and burst firing and the rate of rise and amplitude of low threshold Ca(2+) spikes. These effects were associated with a increase in input resistance. In contrast, the depressant effects of pentobarbital correlated to a decreased input resistance measured with hyperpolarizing current pulse injection (IC(50) = 7.8 microM). Pentobarbital reduced Na(+)-dependent rectification on depolarization and lowered the slope resistance over a wide voltage range. Tetrodotoxin eliminated both Na(+)-dependent rectification and the pentobarbital-induced decrease in membrane resistance at depolarized voltages in two-thirds of the neurons. The pentobarbital-induced decrease in membrane resistance at voltages hyperpolarized from rest was not evident during co-application with Cs(+), known to block the hyperpolarization-activated rectifiers. In summary, the pentobarbital acted at low concentrations to depress thalamocortical neurons. The depression resulted from decreased rectification on depolarization, which no longer boosted potentials over threshold, and an increased conductance that shunted spike generation. The depressant effects of pentobarbital did not involve known types of GABA receptor interactions.


Subject(s)
Auditory Pathways/drug effects , Auditory Pathways/physiology , Hypnotics and Sedatives/pharmacology , Pentobarbital/pharmacology , Receptors, GABA/physiology , Thalamus/drug effects , Thalamus/physiology , Animals , Cesium/pharmacology , Drug Interactions , Electrophysiology , GABA Antagonists/pharmacology , GABA-A Receptor Antagonists , GABA-B Receptor Antagonists , Hypnotics and Sedatives/antagonists & inhibitors , In Vitro Techniques , Neurons/drug effects , Neurons/physiology , Pentobarbital/antagonists & inhibitors , Rats , Rats, Sprague-Dawley
9.
Psychopharmacology (Berl) ; 157(2): 115-22, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11594435

ABSTRACT

RATIONALE: Drugs that are self-administered usually produce a conditioned place preference (CPP) but pentobarbital is self-administered by both animals and humans and is reported to be aversive in the CPP test. OBJECTIVES: We tested whether pentobarbital (5, 15, and 25 mg/kg; IP) could produce a place preference and examined the role of GABA, dopamine (DA) and opioid receptors in the pentobarbital CPP. METHODS: Place conditioning was carried out in an apparatus consisting of two compartments connected by an alley at the rear. During the pre-exposure and test phase, the rats were free to wander in the apparatus for 20 min, and were drug-free. During the 6-day conditioning phase, rats were injected with drug (or vehicle), and confined to one compartment for 30 min and on alternate days were injected with vehicle (or drug) and confined to the other compartment. Upon obtaining a CPP, we examined whether pretreatment of the GABAA antagonists picrotoxin or bicuculline (0.5, 1.0, and 2.0 mg/kg; IP), the DA antagonist eticlopride (0.01, 0.05, and 0.25 mg/kg; SC), or the opioid antagonist naloxone (0.02, 0.20, and 2.0 mg/kg; IP) would block the CPP. RESULTS: 15 mg/kg pentobarbital produced a CPP. The pentobarbital CPP was blocked by pretreatment of 1.0 and 2.0 mg/kg bicuculline, but not by 0.5, 1.0, or 2.0 mg/kg picrotoxin. The pentobarbital CPP was also blocked by 0.05 and 0.25 mg/kg eticlopride and by all of the doses of naloxone tested. CONCLUSIONS: Pretreatment with the antagonists bicuculline, eticlopride, and naloxone blocked a 15 mg/kg pentobarbital CPP. This indicates that GABAergic, dopaminergic, and opioid systems play a role in the reinforcing properties of pentobarbital.


Subject(s)
Cardiotonic Agents/pharmacology , Conditioning, Psychological/drug effects , Dopamine/physiology , Hypnotics and Sedatives/pharmacology , Narcotic Antagonists/pharmacology , Pentobarbital/pharmacology , gamma-Aminobutyric Acid/physiology , Animals , Conditioning, Psychological/physiology , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , GABA Antagonists/pharmacology , Hypnotics and Sedatives/antagonists & inhibitors , Male , Pentobarbital/antagonists & inhibitors , Rats , Rats, Long-Evans
10.
J Ethnopharmacol ; 71(1-2): 65-75, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10904147

ABSTRACT

The ethanolic extracts of leaves of Albizzia lebbeck and flowers of Hibiscus rosa sinesis and the petroleum ether extract of flowers of Butea monosperma exhibited anticonvulsant activity. The bioassay guided fractionation indicated that the anticonvulsant activity lies in the methanolic fraction of chloroform soluble part of ethanolic extract of the leaves of A. lebbeck, acetone soluble part of ethanolic extract of H. rosa sinesis flowers and acetone soluble part of petroleum ether extract of B. monosperma flowers. The fractions protected animals from maximum electro shock, electrical kindling and pentylenetetrazole-induced convulsions in mice. The fractions also inhibited convulsions induced by lithium-pilocarpine and electrical kindling. However, they failed to protect animals from strychnine-induced convulsions. The fractions antagonised the behavioral effects of D-amphetamine and potentiated the pentobarbitone-induced sleep. The fractions raised brain contents of gamma-aminobutyric acid (GABA) and serotonin. These fractions were found to be anxiogenic and general depressant of central nervous system.


Subject(s)
Anticonvulsants/pharmacology , Epilepsy/prevention & control , Plants, Medicinal/chemistry , Amphetamine/antagonists & inhibitors , Amphetamine/toxicity , Animals , Behavior, Animal/drug effects , Brain Chemistry/drug effects , Central Nervous System Stimulants/antagonists & inhibitors , Central Nervous System Stimulants/toxicity , Convulsants , Electroshock , Epilepsy/chemically induced , Hypnotics and Sedatives/antagonists & inhibitors , Hypnotics and Sedatives/pharmacology , Lithium , Male , Mice , Muscarinic Agonists , Pentobarbital/antagonists & inhibitors , Pentobarbital/pharmacology , Pentylenetetrazole , Pilocarpine , Plant Extracts/pharmacology , Plant Leaves/chemistry , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Sleep/drug effects , gamma-Aminobutyric Acid/metabolism
11.
Anesthesiology ; 90(4): 1158-64, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10201689

ABSTRACT

BACKGROUND: Neuronal excitation may result from stimulation of gamma-aminobutyric acid A (GABA(A)) receptors that prolong the channel opening, depolarizing the postsynaptic membrane. Drugs such as acetazolamide or amiloride can block GABA depolarization. Barbiturates facilitate nociceptive reflexes and also prolong the GABA(A) channel open-time. To evaluate the possible mechanism, the authors studied the impact of acetazolamide and amiloride on pentobarbital-induced nocifensive reflex facilitation. Because nitric oxide (NO) is a mediator of reflex facilitation, the authors evaluated the effects of NO synthase inhibition. METHODS: Nocifensive reflex thresholds were quantified with the hind paw withdrawal latency from radiant heat (HPW latency) in the rat. Nocifensive reflexes were facilitated with intraperitoneal injection of pentobarbital (30 mg/kg). The authors tested the roles of GABA-mediated depolarization and NO in reflex facilitation by pretreatment with acetazolamide and amiloride and inhibition of NO synthase with L-NAME and 7-NI, respectively. Sedative effects of pentobarbital were evaluated with the righting reflex, the response to vibrissal stimulation, and plasma drug concentrations. RESULTS: Pentobarbital decreased the hind paw withdrawal latency from 11.2+/-1 to 8.3+/-1 s (P < 0.001). Pretreatment with each of the four test drugs limited the reduction in reflex facilitation after pentobarbital to 1.3 s or less, similar to the reduction seen after saline injection, without altering sedation. L-NAME increased plasma pentobarbital concentrations by 10% without changing the concentration associated with return of responsiveness. CONCLUSIONS: Pentobarbital-induced nocifensive reflex facilitation was inhibited by all four tested drugs without evidence of increased sedation. The results are consistent with a role for GABA(A) receptor-mediated depolarization in barbiturate-induced hyper-reflexia.


Subject(s)
Acetazolamide/pharmacology , Amiloride/pharmacology , GABA Modulators/pharmacology , Pain/physiopathology , Pentobarbital/pharmacology , Receptors, GABA-A/physiology , Reflex/drug effects , Animals , Male , NG-Nitroarginine Methyl Ester/pharmacology , Pentobarbital/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects
12.
Br J Anaesth ; 81(4): 563-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9924233

ABSTRACT

We have compared the effects of isoflurane, propofol, ketamine and pentobarbital on parasympathetic reflex vasodilatation to investigate their involvement in GABA-mediated synaptic inhibition, enhancement of which is thought to underlie the action of many anaesthetic agents. In cats anaesthetized with urethane-alpha-chloralose, parasympathetic reflex vasodilation in the ipsilateral lower lip was elicited by electrical stimulation of the central cut end of the lingual nerve. Isoflurane and pentobarbital both produced marked dose-dependent inhibition of this vasodilator response. In contrast, propofol and ketamine had no effect on parasympathetic reflex vasodilation. Administration of a GABA antagonist (picrotoxin) reversed the inhibition produced by isoflurane (previous results) and pentobarbital (present study). Our results suggest that isoflurane and pentobarbitone inhibit parasympathetic reflex vasodilatation via a GABA-mediated mechanism, but that propofol and ketamine have no such effect. Our results with propofol cast doubt on its presumed mechanism of action as an anaesthetic.


Subject(s)
Anesthetics, Inhalation/pharmacology , Anesthetics, Intravenous/pharmacology , Hypnotics and Sedatives/pharmacology , Parasympathetic Nervous System/drug effects , Vasodilation/drug effects , Animals , Cats , Dose-Response Relationship, Drug , Electric Stimulation , Female , GABA Antagonists/pharmacology , Hypnotics and Sedatives/antagonists & inhibitors , Isoflurane/pharmacology , Ketamine/pharmacology , Lip/blood supply , Male , Pentobarbital/antagonists & inhibitors , Pentobarbital/pharmacology , Picrotoxin/pharmacology , Propofol/pharmacology , Reflex/drug effects
13.
Brain Res ; 754(1-2): 325-8, 1997 Apr 18.
Article in English | MEDLINE | ID: mdl-9134993

ABSTRACT

Central noradrenergic systems have been shown to modulate the hypnotic activity of pentobarbital in mice. To determine whether the GABA(A)/benzodiazepine receptor system is involved in the decrease in pentobarbital sleep caused by activation of central noradrenergic systems, we examined in mice the effects of the benzodiazepine receptor ligands flumazenil and FG7142 on pentobarbital-induced sleep, and on adrenoceptor ligand modulation of pentobarbital sleep. The intracerebroventricular (i.c.v.) administration of methoxamine (8-200 nmol), an alpha1-adrenoceptor agonist, and yohimbine (1-30 nmol), an alpha2-adrenoceptor antagonist, produced a dose-dependent decrease in sleeping time induced by pentobarbital (50 mg/kg, intraperitoneally (i.p.)). The i.c.v. administration of flumazenil (16.5 and 33 nmol), a selective benzodiazepine receptor antagonist, had no effect on pentobarbital sleep, whereas an i.p. injection of FG7142, a selective benzodiazepine receptor inverse agonist, shortened pentobarbital sleep. Flumazenil (33 nmol, i.c.v.) caused the pentobarbital sleep time, shortened by methoxamine (200 nmol, i.c.v.) and yohimbine (30 nmol, i.c.v.), to return to the control level, while FG7142 (10 mg/kg, i.p.) had no effect on the methoxamine- and yohimbine-shortened pentobarbital sleep. These results suggest that putative endogenous benzodiazepine receptor ligands with an inverse agonist-like property are involved in the methoxamine- and yohimbine-induced decrease in pentobarbital sleep in mice.


Subject(s)
Carbolines/pharmacology , Cerebral Ventricles/physiology , Flumazenil/pharmacology , Pentobarbital/pharmacology , Sleep/drug effects , Animals , Appetite Depressants/pharmacology , Carbolines/administration & dosage , Cerebral Ventricles/drug effects , Flumazenil/administration & dosage , Injections, Intravenous , Injections, Intraventricular , Male , Methoxamine/administration & dosage , Methoxamine/pharmacology , Mice , Mice, Inbred Strains , Pentobarbital/administration & dosage , Pentobarbital/antagonists & inhibitors , Yohimbine/administration & dosage , Yohimbine/pharmacology
14.
J Neurosci ; 17(2): 625-34, 1997 Jan 15.
Article in English | MEDLINE | ID: mdl-8987785

ABSTRACT

Anesthetic drugs are known to interact with GABAA receptors, both to potentiate the effects of low concentrations of GABA and to directly gate open the ion channel in the absence of GABA; however, the site(s) involved in direct gating by these drugs is not known. We have studied the ability of alphaxalone (an anesthetic steroid) and pentobarbital (an anesthetic barbiturate) to directly activate recombinant GABAA receptors containing the alpha 1, beta 2, and gamma 2L subunits. Steroid gating was not affected when either of two mutated beta 2 subunits [beta 2 (Y157S) and beta 2 (Y205S)] are incorporated into the receptors, although these subunits greatly reduce the affinity of GABA binding. These observations indicate that steroid binding and subsequent channel gating do not require these particular residues, as already shown for barbiturates. Bicuculline or gabazine (two competitive antagonists of GABA binding) reduced the currents elicited by alphaxalone and pentobarbital from wild-type GABAA receptors; however, gabazine produced only a partial block of response pentobarbital or alphaxalone, and bicuculline only partially blocked responses to pentobarbital. These observations indicate that the blockers do not compete with alphaxalone or pentobarbital for a single class of sites on the GABAA receptor. Finally, at receptors containing alpha 1 beta 2 (Y157S) gamma 2L subunits, both bicuculline and gabazine showed weak agonist activity and actually potentiated responses to alphaxalone. These observations indicate that the blocking drugs can produce allosteric changes in GABAA receptors, at least those containing this mutated beta 2 subunit. We conclude that the sites for binding steroids and barbiturates do not overlap with the GABA-binding site. Furthermore, neither gabazine nor bicuculline competes for binding at the steroid or barbiturate sites. The data are consistent with a model in which both gabazine and bicuculline act as allosteric inhibitors of channel opening for the GABAA receptor after binding to the GABA-binding site.


Subject(s)
Bicuculline/pharmacology , GABA Antagonists/pharmacology , Ion Channel Gating/drug effects , Pyridazines/pharmacology , Receptors, GABA-A/drug effects , Allosteric Regulation , Allosteric Site , Amino Acid Sequence , Animals , Bicuculline/metabolism , Binding Sites , Binding, Competitive , Cell Line , Coturnix , GABA Antagonists/metabolism , GABA Modulators/antagonists & inhibitors , GABA Modulators/metabolism , Ion Transport/drug effects , Models, Chemical , Molecular Sequence Data , Mutagenesis, Site-Directed , Patch-Clamp Techniques , Pentobarbital/antagonists & inhibitors , Pentobarbital/metabolism , Point Mutation , Pregnanediones/antagonists & inhibitors , Pregnanediones/metabolism , Pregnanolone/pharmacology , Protein Binding , Pyridazines/metabolism , Receptors, GABA-A/chemistry , Receptors, GABA-A/genetics , Receptors, GABA-A/metabolism , Structure-Activity Relationship , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacology
15.
Nihon Yakurigaku Zasshi ; 110 Suppl 1: 33P-38P, 1997 Oct.
Article in Japanese | MEDLINE | ID: mdl-9503402

ABSTRACT

Taltirelin hydrate[1-methyl-(S)-4,5-dihydroorotyl-L-histidyl-L-prolineamide tetrahydrate] is a new orally active thyrotropin releasing hormone (TRH) peptide analog synthetized from aspartic acid. From preclinical studies with mice and rats, Taltirelin hydrate was found to be highly stable in the blood and brain as compared with TRH. Furthermore, the CNS stimulating actions of Taltirelin hydrate such as antagonistic actions against pentobarbital-induced anesthesia and reserpine- induced hypothermia were found to be about 100 times stronger and about 8 times longer-lasting as compared with those of TRH. Meanwhile, the affinity of Taltirelin hydrate for TRH-receptors was about 10 times lower, and the endocrine action was about 5 times less potent than those of TRH. Therefore, high CNS-selectivity and long-lasting action of Taltirelin hydrate would be attributed to its high stability in the body and low affinity for TRH-receptors. Oral administrations of Taltirelin hydrate ameliorated consiousness impairment, memory impairment and motor dysfunction in several models. The clinical studies for patients with spinocerebellar degeneration are in progress.


Subject(s)
Nootropic Agents/chemical synthesis , Thyrotropin-Releasing Hormone/analogs & derivatives , Animals , Aspartic Acid , Drug Stability , Humans , Mice , Nootropic Agents/pharmacokinetics , Nootropic Agents/pharmacology , Pentobarbital/antagonists & inhibitors , Rats , Receptors, Thyrotropin-Releasing Hormone/metabolism , Reserpine/antagonists & inhibitors , Thyrotropin-Releasing Hormone/chemical synthesis , Thyrotropin-Releasing Hormone/pharmacokinetics , Thyrotropin-Releasing Hormone/pharmacology
16.
Neuroreport ; 8(1): 139-41, 1996 Dec 20.
Article in English | MEDLINE | ID: mdl-9051768

ABSTRACT

Recent reports have confirmed the involvement of neurosteroids in a number of neurophysiological processes, including sleep, and that these compounds interact with the gamma-aminobutyric acid receptor A complex. As many of the behavioural effects of pentobarbital are as a result of the activity at this complex, we investigated the role of corticosteroid-like neurosteroids in regulation of sleep, using metyrapone as a tool. Metyrapone, a blocker of the enzyme 11 beta-hydroxylase, which is essential for the biosynthesis of corticosteroids, when administered intracerebroventricularly (i.c.v.) at low doses (50-5000 ng) caused a dose-dependent reduction in sleep time induced by pentobarbital. This effect was, however, antagonized by concomitant administration of anti-corticotropin-releasing factor antisera. The present study reveals for the first time that corticosteroid-like neurosteroids might be involved in the regulation of CNS excitability.


Subject(s)
Adrenal Cortex Hormones/physiology , Hypnotics and Sedatives/pharmacology , Neurotransmitter Agents/physiology , Pentobarbital/pharmacology , Sleep/physiology , Animals , Dose-Response Relationship, Drug , Hypnotics and Sedatives/antagonists & inhibitors , Injections, Intraventricular , Male , Metyrapone/administration & dosage , Metyrapone/pharmacology , Pentobarbital/antagonists & inhibitors , Rats , Rats, Wistar , Sleep/drug effects
17.
Brain Res ; 725(2): 272-5, 1996 Jul 01.
Article in English | MEDLINE | ID: mdl-8836536

ABSTRACT

Intracerebroventricular injection of neuropeptide Y (NPY) prolonged sodium pentobarbital (PhNa)-induced sleep in rats. The prolongation of PbNa-induced sleep by NPY was blocked by naloxone. Both corticotropin-releasing hormone and psychological stress caused shortening of PbNa-induced sleep, and the shortening was reversed by NPY. These results suggest that NPY has a sedative action and that an opioid system in the brain mediates at least in part the action of NPY.


Subject(s)
Corticotropin-Releasing Hormone/antagonists & inhibitors , Hypnotics and Sedatives/antagonists & inhibitors , Neuropeptide Y/pharmacology , Pentobarbital/antagonists & inhibitors , Sleep/drug effects , Stress, Psychological/drug therapy , Animals , Male , Motor Activity/drug effects , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Rats , Rats, Wistar , Time Factors
18.
Eur J Pharmacol ; 307(1): 89-96, 1996 Jun 20.
Article in English | MEDLINE | ID: mdl-8831109

ABSTRACT

In voltage clamped cultured hippocampal neurons, application of gamma-aminobutyric acid (GABA) or pentobarbitone induced chloride current in a dose-dependent manner. The dose dependence of these agonists were well described by ED50 and Hill coefficients of 14.7 +/- 7 microM and 1.2 +/- 0.5, and 299 +/- 17.3 microM and 1.6 +/- 0.1, for GABA and pentobarbitone, respectively. The effects of two GABAA receptor antagonists, bicuculline and 2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide (SR95531) were evaluated by co-application of increasing concentrations of the antagonists with a fixed equipotent (approximately ED30) dose of GABA or pentobarbitone. Both bicuculline and SR95531 blocked the GABA induced current with ID50 and Hill coefficients of 0.74 +/- 0.07 microM and 0.96 +/- 0.07, and 0.44 +/- 0.02 microM and 1.22 +/- 0.06, respectively. Bicuculline similarly blocked the pentobarbitone induced current with a ID50 and Hill coefficient of 0.69 +/- 0.04 microM and 1.2 +/- 0.1. However, pentobarbitone induced current was poorly blocked by SR95531 retaining 86.5% of current amplitude at a concentration of SR95531, 200 times the IC50 for GABA induced current. Current induced by etomidate, another intravenous general anesthetic with GABAA receptor agonistic property, is likewise resistant to SR95531 blockade. Three-dimensional modeling of bicuculline and SR95531 with alignment of the molecules along the suggested GABA-receptor binding moiety indicates that these two antagonist molecules have distinct steric properties. We suggest that GABA and pentobarbitone act at nearby but non-identical sites on the hippocampal GABAA receptor to open the chloride ionophore, and that these sites can be distinguished by bicuculline and SR95531. This is the first demonstration that the prototypic GABAA site antagonists bicuculline and SR95531 have different effects on currents induced by GABA and pentobarbitone.


Subject(s)
Bicuculline/pharmacology , Chloride Channels/physiology , GABA Antagonists/pharmacology , GABA Modulators/pharmacology , Hippocampus/drug effects , Hippocampus/physiology , Pentobarbital/antagonists & inhibitors , Pyridazines/pharmacology , Anesthetics, General/pharmacology , Anesthetics, Intravenous/pharmacology , Animals , Binding Sites , Cells, Cultured , Chloride Channels/drug effects , Chlorides/metabolism , Etomidate/pharmacology , GABA Agonists/pharmacology , Hippocampus/metabolism , Models, Molecular , Neurons/drug effects , Neurons/metabolism , Neurons/physiology , Pentobarbital/pharmacology , Rats , Receptors, GABA-A/drug effects , Receptors, GABA-A/physiology , gamma-Aminobutyric Acid/pharmacology
19.
Nihon Yakurigaku Zasshi ; 107(5): 237-45, 1996 May.
Article in Japanese | MEDLINE | ID: mdl-8690305

ABSTRACT

Effects of a novel TRH analog, montirelin hydrate (NS-3), on the coma caused by head concussion and narcosis induced by pentobarbital were compared with those of TRH in mice. Head concussion caused a behavioral comatose state with loss of the righting reflex and spontaneous motor activity. NS-3 shortened the latent periods to the recovery of the righting reflex (0.03-0.1 mg/kg, i.v.) and spontaneous motor activity (0.1 mg/kg, i.v.) following the head concussion. In the case of TRH, higher doses were needed to induce such effects. NS-3 (0.1-0.3 mg/kg, i.v.) reversed the pentobarbital-induced narcosis in a dose-dependent manner. A similar effect was elicited by 30- to 100-fold higher doses of TRH than NS-3. The analeptic effect of NS-3 in the pentobarbital-narcotized mice was antagonized by SCH23390, a dopamine D1 antagonist or by the combined treatment with prazosin and scopolamine, while neither prazosin nor scopolamine alone antagonized the analeptic effect of NS-3. Taken together with the finding that NS-3 did not bind to dopamine, adrenaline or muscarine receptors, it is suggested that NS-3 may restore the disturbance of consciousness by activating the brain dopamine, noradrenaline and acetylcholine neurons without stimulating these receptors directly.


Subject(s)
Brain Concussion/complications , Consciousness Disorders/drug therapy , Pentobarbital/antagonists & inhibitors , Thyrotropin-Releasing Hormone/analogs & derivatives , Anesthesia , Animals , Consciousness Disorders/etiology , Male , Mice , Mice, Inbred Strains , Rats , Rats, Wistar , Receptors, Catecholamine/drug effects , Receptors, GABA/drug effects , Receptors, Muscarinic/drug effects , Receptors, Opioid/drug effects , Thyrotropin-Releasing Hormone/pharmacology , Thyrotropin-Releasing Hormone/therapeutic use
20.
Eur J Pharmacol ; 292(1): 39-42, 1994 Nov 01.
Article in English | MEDLINE | ID: mdl-7867688

ABSTRACT

We studied the effect of the reducing agents dithiothreitol and dithioerythritol (Cleland's reagents) on the hypnotic and toxic effects of pentobarbital in rodents. In pentobarbital anesthetized rats (50 mg/kg), the i.v. infusion of dithioerythritol (84 mumol/kg/min for 10 min) accelerated the return of eyeblink and righting reflexes (to 4 +/- 1 min vs. 22 +/- 2 min,k and 15 +/- 1 vs. 65 +/- 8 min respectively (P < 0.001). In mice receiving lethal doses of pentobarbital, the 4 h LD50 was 128 +/- 2 mg/kg; when dithioerythritol was given simultaneously, LD50 was > 165 mg/kg. Dithiothreitol also had a protective effect in rats. Oxidized dithiothreitol or dithioerythritol had no effect on pentobarbital sleeping time or mortality. The protective effect of dithioerythritol was dose-dependent; a high dose (294 mg/kg) gave complete protection in the short term, but killed the mice subsequently. The study shows that Cleland's reagents or their derivatives can act as pentobarbital antagonists in rodents, although side effects limit that usefulness. It also suggests caution in the use of dithiothreitol and related compounds during pentobarbital anesthesia.


Subject(s)
Dithioerythritol/pharmacology , Dithiothreitol/pharmacology , Pentobarbital/antagonists & inhibitors , Pentobarbital/toxicity , Animals , Dose-Response Relationship, Drug , Drug Interactions , Male , Mice , Oxidation-Reduction , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...